|
Auditory Function in Patients With and Without Multiple Sclerosis Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Auditory Function in Patients With and Without Multiple Sclerosis conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Auditory Function in Patients With and Without Multiple Sclerosis Clinical research trials and Auditory Function in Patients With and Without Multiple Sclerosis medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Auditory Function in Patients With and Without Multiple Sclerosis. Auditory Function in Patients With and Without Multiple Sclerosis Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Auditory Function in Patients With and Without Multiple Sclerosis clinical trial. Participants frequently obtain the most expert healthcare available for their Auditory Function in Patients With and Without Multiple Sclerosis condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Auditory Function in Patients With and Without Multiple Sclerosis  Auditory Function in Patients With and Without Multiple Sclerosis
Auditory Function in Patients With and Without Multiple Sclerosis
For Condition: Multiple Sclerosis
Status: Recruiting
Sponsor(s): Department of Veterans Affairs Rehabilitation Research and Development Service ,
Synopsis: We propose to evaluate auditory function and neuropsychologic function in 150 Multiple Sclerosis (MS) patients and in 150 patients who do not have MS. Experimental subjects will be recruited by selecting patients with a verified diagnosis of MS from the registry of patients established by the Oregon Health Sciences University, Multiple Sclerosis Research Center. Control subjects will be matched with respect to age, to gender and to audiometric configuration.
Details: This study will compare the prevalence and nature of hearing dysfunction in patients with MS and in a group of control subjects without MS. The work will address three main goals: 1) Evaluating the possibility that MS is a risk factor for hearing impairment, tinnitus and central auditory dysfunction. 2) Determining the nature and the extent of auditory dysfunction in individuals with MS compared to those without MS; and determining neuropsychological function in each group. 3) Evaluating the extent to which disability in individuals with MS may be amplified by the presence of auditory dysfunction. Measurements of auditory function and psychometric performance will be compared between MS patients and control subjects without MS. These subjects will come to the Portland VAMC for four sessions of comprehensive auditory and psychometric testing. Additional information on disease history and status, hearing history, and current-disability status will be obtained. Subjects The patient group (Group 1) will consist of 150 patients with diagnosed MS, recruited at the MS Center of Oregon. For this group, inclusion criteria for each patient will include: (1) a clinical or laboratory supported diagnosis of "definite MS" (Poser, et al., 1983); (2) a diagnosis of relapsing, remitting or secondary progressive MS; (3) A Kurtzke Expanded Disability Status Score (EDSS) of 0 to 7.0, inclusive; (4) no history of a clinical relapse or change in EDSS for three months preceding entry into the study; and (5) a brain MRI scan (within the preceding year) that shows at least three white-matter lesions on T2-weighted images consistent with MS. The control group (Group 2) will consist of 150 subjects without MS who are matched to the patient group with respect to age (± 5 years), to gender and to audiometric configuration (within ±10 dB Hearing Level for the octave test frequencies from 500 through 8000 Hz). Subjects in Group 2 will be recruited from the VA audiology clinic and from a cohort of more than 360 subjects and patients who have been used as controls in five other studies. Both males and non-pregnant females will be recruited in equal numbers. Minority individuals will be recruited in accordance with recommendations for proportional minority representation established by the Office of Human Research Accountability and the Minority Affairs Program. The protocols will be explained verbally by the investigators, and restated in consent forms approved by the VA IRB, and signed by the subject, by the investigator and by a witness.
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Multiple Sclerosis
Total Enrollment: 300
Location and Contact Information:
Overall Study Official:
DavidWolff, , Program Analysis and Review Section (PARS), VA Rehabilitation Research & Development Service
VA Medical Center *Recruiting*
Portland, Oregon,
United States
Recruiting David Lilly 503-220-8262
Additional Information:
Study ID Numbers: B2568;
Study Start Date: October 2001
Record last reviewed: May 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00037947
Other Multiple Sclerosis Studies:
1. Induction Therapy with a Single High Dose Bolus of Intravenous Methotrexate with Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting with a First Acute Demyelinating Event.
2. Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis
3. Yoga: Effect on Attention in Aging & Multiple Sclerosis
4. Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
5. A study to evaluate the preliminary efficacy pharmacokinetics and immunogenicity of BMS-188667 administered to subjects with relapsing-remitting multiple sclerosis
Related Studies:
Other Multiple Sclerosis Clinical Trials
Other Oregon Clinical Trials
Other Portland Clinical Trials
Auditory Function in Patients With and Without Multiple Sclerosis
|
|
|
|
|
|
|
|
